Thesis

Street consensus, scenarios, merits, risks, and invalidation triggers

AI-assisted
Thesis Summary

Ecolab's operating outlook is constructive: second-quarter organic sales growth accelerated to 5%, organic operating income margin reached 18.8%, and adjusted EPS increased 11%. Global High-Tech and Life Sciences provide differentiated growth, while CoolIT broadens Ecolab's exposure to AI data-center cooling. The offset is meaningful execution risk from commodity inflation, geopolitical disruption, acquisition integration, and near-term CoolIT financing and amortization costs.

Sign in / Sign up to read more
This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today.
Street view · analyst 12-month targets21 analysts · as of 18 Aug 2026
Low · most bearish analyst$295.00
Mean target$324.67
High · most bullish analyst$360.00
Our research · scenarios, merits, risks, and invalidation triggersResearch as of 2 Sep 2026
Scenarios · 12-month scenario targetsAnchored at research date
Bear CaseDownside scenario
$295.0020%

Pricing fails to offset rising commodity and supply-chain costs, geopolitical disruption weighs on customer activity, and CoolIT integration or financing costs persist longer than expected. Organic sales growth falls below the second-half outlook, margin expansion stalls, and Global High-Tech growth undershoots the rate required to support its 2030 target.

Base CaseCentral scenario
$324.6750%
Matches the consensus mean

Ecolab delivers within its $8.05-$8.25 adjusted EPS outlook for 2026, with second-half organic sales growth near 6%-7% and margin progression supported by pricing and productivity. Core operations remain resilient and Global High-Tech scales, but CoolIT financing and amortization costs temper near-term EPS growth.

Bull CaseUpside scenario
$360.0030%

Organic growth reaches or exceeds the 6%-7% second-half outlook, pricing fully offsets commodity inflation, and organic operating margin advances beyond approximately 20%. CoolIT and Ovivo strengthen Global High-Tech growth, keeping the platform on track for more than 25% annual growth and $4 billion of sales by 2030, while adjusted EPS returns toward management's 12%-15% long-term algorithm after the near-term acquisition-cost effect subsides.

Scenarios are anchored to street consensus at the research date, with our probabilities and rationale.

Key Investment Merits
  • Second-quarter 2026 organic sales grew 5%, organic operating income margin expanded to 18.8%, and adjusted diluted EPS rose 11%.
  • Global High-Tech and Life Sciences grew 29% and 15%, respectively, in the second quarter, providing faster-growth platforms alongside Ecolab's core businesses.
  • The CoolIT acquisition extends Ecolab across AI infrastructure water and cooling, with Global High-Tech targeting $4 billion of annual sales and a 25% operating margin by 2030.
Sign in / Sign up to read more
Key Investment Risks
  • Rising commodity costs and customer disruption associated with Middle East conflict could pressure volume, gross margin, and earnings.
  • The approximately $4.75 billion CoolIT acquisition creates integration, financing-cost, and non-cash amortization risks before its expected growth contribution matures.
  • The investment case depends on sustained pricing, productivity, and execution against ambitious Global High-Tech growth and margin targets.
Sign in / Sign up to read more

All scenarios are estimates and subject to change. Past performance is not indicative of future results.

Quality Pillars Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Explore this dossier

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.